zm 336372 has been researched along with Rheumatoid Arthritis in 1 studies
N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DS | 1 |
| Belfield, AJ | 1 |
| Brown, GR | 1 |
| Campbell, D | 1 |
| Foubister, A | 1 |
| Masters, DJ | 1 |
| Pike, KG | 1 |
| Snelson, WL | 1 |
| Wells, SL | 1 |
1 other study available for zm 336372 and Rheumatoid Arthritis
| Article | Year |
|---|---|
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.
Topics: Amides; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; In Vitro Techniques; Leukocyte | 2004 |